In medical research, IBD2 refers to a specific transcriptomic, prognostic subgroup in inflammatory bowel disease associated with a less aggressive disease course, as studied in trials like BOOM-IBD2. In genetics, the term denotes "Identity-By-Descent," where individuals share two alleles on a DNA segment inherited from a common ancestor. For more information on the BOOM-IBD2 clinical trial, visit Sutter Health . A blood-based prognostic biomarker in IBD - Gut
In medical research, IBD2 refers to a specific transcriptomic, prognostic subgroup in inflammatory bowel disease associated with a less aggressive disease course, as studied in trials like BOOM-IBD2. In genetics, the term denotes "Identity-By-Descent," where individuals share two alleles on a DNA segment inherited from a common ancestor. For more information on the BOOM-IBD2 clinical trial, visit Sutter Health . A blood-based prognostic biomarker in IBD - Gut